Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 8/20 | 0.54 |
| ▸ | CCKBR | P32239 | 2/20 | 0.50 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30522174 | 0.88 | CCKBR (0.58) | CCKBRQRFPRPTPN1 | |
| SCHEMBL27644660 | 0.84 | QRFPR (0.55) | QRFPR | |
| SCHEMBL27644664 | 0.84 | QRFPR (0.55) | QRFPR | |
| SCHEMBL29708271 | 0.84 | TFPI (0.56) | CCKBR | |
| SCHEMBL29592613 | 0.83 | BACE1 (0.61) | BACE1 | |
| SCHEMBL8150753 | 0.81 | KISS1R (0.55) | KISS1RRENQRFPRBACE1 | |
| SCHEMBL30527842 | 0.81 | KISS1R (0.55) | KISS1RBACE1 | |
| SCHEMBL29416105 | 0.81 | KISS1R (0.55) | KISS1RBACE1 | |
| SCHEMBL30769684 | 0.81 | TFPI (0.57) | KISS1RQRFPRBACE1PTPN1 | |
| SCHEMBL11225559 | 0.81 | LTA4H (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | KISS1R 1232/4885CCKBR 257/4885REN 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.